Ask AI

Clinical Impact of New HIV Data

Share

Program Content

Activities

  • Podcast: Conference Conversations for Pharmacists
    Conference Conversations: HIV Pharmacist Perspectives from CROI 2022
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2022

  • Podcast: Conference Conversations for APPs
    Conference Conversations: HIV Advanced Practice Provider Perspectives from CROI 2022
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 16, 2022

  • Slides: CROI 2022
    Key HIV Studies Influencing My Practice Following CROI 2022
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 02, 2022

  • Audio Recap: CROI 2022
    Key HIV Studies Influencing My Practice Following CROI 2022—Audio Recap
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 14, 2022

  • ClinicalThought: MI Risk in PWH
    MI Risk in PWH: New Data From CROI 2022
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 16, 2022

  • ClinicalThought: Long-Acting ART
    From CROI 2022: Week 152 ATLAS-2M Results on LA ART and Implications for Patients
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 15, 2022

  • ClinicalThought: COVID Testing
    What the Latest Data—Including Presentations From CROI 2022—Teach Us About SARS-CoV-2 Testing
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2022

Activities

VISEND Study
VISEND: Switching From NNRTI-Based to PI-Based ART vs DTG + Recycled NRTIs
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Monthly Islatravir for PrEP
Protocol 016: Wk 24 Metabolic and Renal Outcomes Similar for Monthly Oral Islatravir vs Placebo as HIV PrEP in Phase IIa Study
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2022

CALIBRATE Primary Analysis
CALIBRATE: Wk 54 Primary Analysis of Long-Acting Subcutaneous Lenacapavir in Treatment-Naive Patients
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

CAPELLA
CAPELLA: Wk 52 Results With Long-acting SC Lenacapavir in Persons With Multidrug-Resistant HIV
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2022

SALSA Post hoc Analysis
SALSA Post hoc Analysis: Proportion of Patients With Baseline Archived Resistance Attaining Stringent Efficacy Criteria After Switch to DTG/3TC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2022

HPTN 083 Update
HPTN 083: Updated Safety and Efficacy of Long-Acting Injectable CAB vs Daily Oral FTC/TDF as HIV PrEP in MSM and TGW
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Cognitive Impairment
ACTG A5324: Intensification of ART in People With HIV on Suppressive ART Does Not Improve Cognitive Impairment
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2022

HIV and Pregnancy Prevention
Feasibility of Long-Acting Combination HIV and Pregnancy Prevention Implant Demonstrated in Mouse Model
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Imbokodo Vaccine Study
Imbokodo: Phase IIb Trial of Heterologous HIV-1 Vaccine Regimen Among Women in Sub-Saharan Africa at High Risk for HIV Infection
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2022

NADIA: DTG Second-line ART
NADIA: Wk 96 Results With DTG vs DRV/RTV and TDF vs ZDV as Second-line ART in Africa
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Provided by

ProCE Banner

Supporters

Cepheid

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck & Co., Inc.

ViiV Healthcare